Kingchem (Liaoning) Life Science Co., Ltd. (SHE:301509)
25.81
-0.51 (-1.94%)
At close: Nov 13, 2026
SHE:301509 Revenue
Kingchem (Liaoning) Life Science had revenue of 154.78M CNY in the quarter ending September 30, 2026, with 11.10% growth. This brings the company's total for the last twelve months to 615.76M, up 3.05% year-over-year. In the year 2025, Kingchem (Liaoning) Life Science had annual revenue of 639.37M with 28.64% growth. That makes Kingchem (Liaoning) Life Science the 23,296th largest company in the world by revenue and 4,205th in China.
Revenue (ttm)
615.76M
Revenue Growth
+3.05%
P/S Ratio
5.05
Revenue / Employee
892.41K
Employees
690
Market Cap
3.11B
Revenue by Geography
- Other Countries and Regions 426.10M 66.6%
- Mainland China 213.28M 33.4%
Fiscal year ended Dec 31, 2025 See the full SHE:301509 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 639.37M | 142.36M | 28.64% |
| Dec 31, 2024 | 497.01M | -269.81M | -35.19% |
| Dec 31, 2023 | 766.82M | 50.15M | 7.00% |
| Jan 1, 2023 | 716.67M | 167.48M | 30.50% |
| Dec 31, 2021 | 549.19M | 84.77M | 18.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Neptunus Bioengineering | 21.33B |
| Zhuhai Rundu Pharmaceutical | 1.34B |
| Huaren Pharmaceutical | 1.22B |
| ChengDu ShengNuo Biotec | 962.54M |
| Shaanxi Panlong Pharmaceutical Group | 917.38M |
| PKU HealthCare Corp.,Ltd. | 903.60M |
| Harbin Medisan Pharmaceutical | 831.90M |
| Shandong Wohua Pharmaceutical | 781.18M |